B.Sc. Medical Technology (Radiotherapy)

Under Graduate – B.Sc. Medical Technology (Radiotherapy)

B.Sc. Medical Technology (Radiotherapy)

The curriculum of B.Sc. in Medical Radiotherapy Technology (BRT) includes basics of Anatomy & Physiology, Radiobiology, Clinical Radiation Therapy including cancer prevention screening and palliation in cancer, Medical radiation physics and Radiation safety.

Students are provided patient - care environment with meaningful communications and problem-solving skills.  Our students are trained on different image planning and Radiotherapy equipment – CT simulation, mould room, and Radiotherapy delivery procedures/techniques by mega voltage machines like linear accelerators dual energy for conventional/3DCRT/IMRT and Brachytherapy for cancer treatment. They are also trained in quality assurance procedures and networking of Radiotherapy images.

Experienced faculty teach and mentor students in therapy and research related programmes.

Eligibility

Eligibility Criteria - B.Sc. Medical Technology(BRT)

Programme Level

BRT

Duration

3 years + 6months Internship

Eligibility criteria apply for admission to B.Sc. Medical Technology programmes (Operation Theatre, Optometry, Laboratory, Radiography & Imaging, Radio-therapy):

• Candidates must have successfully completed 10+2 (CBSE/ISC/Intermediate Board or equivalent) after 12 years of study, with the last two years including Physics, Chemistry, Biology/Biotechnology/Healthcare Sciences, and English from a recognised board.
• A minimum of 50% aggregate marks is required in Physics, Chemistry.

Fee Structure 2025 Criteria - B.Sc. Medical Technology(BMLT/BRIT/BRT/ BOT)/ B.OPTOM / BPT/BASLP

Fee Structure

Merit Scholarship

Up to 100% of Tuition Fees

Merit Cum Means Scholarship

Up to 50% of Tuition Fees

Loan Facility

Interest free education loan

Special Scholarship

Up to 100% of Tuition Fees for: Ward of Armed / Para Military / Police Force Personnel (Serving and Retd, Non-Commissioned Officer), Differently abled candidate, Transgender

Free-Ship Scholarship

Free education to one candidate in each academic program of the University who is an orphan

SRHU University

Your Future Begins Here

Apply Now
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.